Advanced Genomic Testing Karius offers advanced genomic testing solutions using AI and genomics to map a patient's microbial landscape from a single blood sample, providing clinicians with valuable insights for rapid treatment decisions. This unique testing method can be positioned as cutting-edge technology in the market.
Strategic Funding Rounds Recent funding rounds of $100 million from prominent investors like Khosla Ventures, Gilde Healthcare, and 5AM Ventures indicate substantial financial backing and confidence in Karius' innovative approach. Leverage these strategic investments to showcase stability and growth potential to potential clients.
Renowned Industry Experts Karius has onboarded experienced professionals like Norman Sharpless M.D. and Elizabeth O'Farrell to its executive team and board of directors. Highlighting the expertise and reputation of these industry leaders can help build credibility and trust with healthcare institutions and decision-makers.
Adoption in Medical Guidelines The incorporation of Karius Test into the 2023 Duke-ISCVID Criteria for Infective Endocarditis by the International Society of Cardiovascular Infectious Diseases reflects the validation of Karius' technology in the medical community. Use this recognition to demonstrate industry acceptance and relevance in infectious disease diagnostics.
Competitive Landscape Analysis Understanding key competitors like GenMark Diagnostics, T2 Biosystems, and genedrive in terms of employees, revenue, and offerings can help tailor sales strategies and differentiate Karius' genomic diagnostics for infectious diseases. Highlight areas of superiority or differentiation to position Karius as a preferred choice in the market.
Karius uses 8 technology products and services including AppNexus, Apache Airflow, Salesforce Customer 360, and more. Explore Karius's tech stack below.
| Karius Email Formats | Percentage |
| First.Last@kariusdx.com | 87% |
| FLast@kariusdx.com | 7% |
| First@kariusdx.com | 5% |
| Last@kariusdx.com | 1% |
Biotechnology ResearchCalifornia, United States51-200 Employees
Karius sees a world where infectious disease is no longer a major threat to human health. The Karius Test uses genomics and AI to map a patient’s microbial landscape from a single blood sample to enable clinicians to make rapid treatment decisions.
Company Overview
Media & News
Funding & FinancialsKarius has raised a total of $100M of funding over 5 rounds. Their latest funding round was raised on May 02, 2024 in the amount of $100M.
Karius's revenue is in the range of $10M$50M
Funding & FinancialsKarius has raised a total of $100M of funding over 5 rounds. Their latest funding round was raised on May 02, 2024 in the amount of $100M.
Karius's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com